Why Roku Stock Is Down 85% This Year
The media-streaming tech developer took a price cut while sales soared. So what’s going on here?
Mindfully Curated
The media-streaming tech developer took a price cut while sales soared. So what’s going on here?
Is Advanced Micro Devices cutting down supply for its newest consumer processor?
Shares of the retail stock were up on a proposed debt exchange.
It was another disappointing weekend for domestic multiplex operators, but help is on the way.
The Warren Buffett-led conglomarate has been a big outperformer, but what about the next 20 or 30 years?
Economic concerns took a back seat today.
If the cruise business is so great, then why does Carnival Corporation have to keep borrowing money?
Investors’ enthusiasm about positive earnings reports from other companies is spilling over to Teladoc.
Better-than-expected bank earnings are pushing stocks higher.
A product enhancement and broad market tailwinds lifted the software stock.
The crypto bank reported its third-quarter earnings this morning.
Companies haven’t had to worry about inventory for more than two years, but that might change this quarter.
Amazon and MGM could help turbocharge your investment portfolio.
These companies have proven track records of growth that should continue this decade.
There’s more bad news coming for these beaten-down chipmakers.
Amazon’s e-commerce pays the bills, but AWS truly sets Amazon apart.
Jacks and barracuda in He?eia fishpond were found to feed on Australian mullet, an invasive species introduced to Oahu waters in the 1950s. This recently published finding suggests that these native predatory fish may provide a form of biocontrol on po…
Jacks and barracuda in He?eia fishpond were found to feed on Australian mullet, an invasive species introduced to Oahu waters in the 1950s. This recently published finding suggests that these native predatory fish may provide a form of biocontrol on po…
Researchers have demonstrated a promising new approach to delivering immunotherapy agents to fight cancer. The approach involves tethering an immunotherapy agent called a STING agonist to an acid-seeking molecule called pHLIP® (pH-low insertion peptide…
Researchers have demonstrated a promising new approach to delivering immunotherapy agents to fight cancer. The approach involves tethering an immunotherapy agent called a STING agonist to an acid-seeking molecule called pHLIP® (pH-low insertion peptide…